129 related articles for article (PubMed ID: 17240253)
1. Mechanism of action of the angiostatic cortisene anecortave acetate.
Clark AF
Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S26-34. PubMed ID: 17240253
[TBL] [Abstract][Full Text] [Related]
2. Preclinical safety of anecortave acetate.
Heaton J; Kastner P; Hackett R
Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S35-40. PubMed ID: 17240255
[TBL] [Abstract][Full Text] [Related]
3. Preclinical efficacy of anecortave acetate.
Clark AF
Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S41-8. PubMed ID: 17240256
[TBL] [Abstract][Full Text] [Related]
4. Safety of posterior juxtascleral depot administration of the angiostatic cortisene anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration.
Augustin AJ; D'Amico DJ; Mieler WF; Schneebaum C; Beasley C
Graefes Arch Clin Exp Ophthalmol; 2005 Jan; 243(1):9-12. PubMed ID: 15290154
[TBL] [Abstract][Full Text] [Related]
5. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.
Penn JS; Rajaratnam VS; Collier RJ; Clark AF
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):283-90. PubMed ID: 11133880
[TBL] [Abstract][Full Text] [Related]
6. [Present status of studies on the treatment of choroidal neovascularization by Anecortave acetate].
Li X; Wang YS
Zhonghua Yan Ke Za Zhi; 2008 Jun; 44(6):571-4. PubMed ID: 19035252
[TBL] [Abstract][Full Text] [Related]
7. Anecortave acetate for the treatment of exudative age-related macular degeneration--a review of clinical outcomes.
Russell SR; Hudson HL; Jerdan JA;
Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S79-90. PubMed ID: 17240260
[TBL] [Abstract][Full Text] [Related]
8. First clinical experience with anecortave acetate (Retaane).
Hayek S; Scherrer M; Barthelmes D; Fleischhauer JC; Kurz-Levin MM; Menghini M; Helbig H; Sutter FK
Klin Monbl Augenheilkd; 2007 Apr; 224(4):279-81. PubMed ID: 17458792
[TBL] [Abstract][Full Text] [Related]
9. Identification of PDE6D as a molecular target of anecortave acetate via a methotrexate-anchored yeast three-hybrid screen.
Shepard AR; Conrow RE; Pang IH; Jacobson N; Rezwan M; Rutschmann K; Auerbach D; Sriramaratnam R; Cornish VW
ACS Chem Biol; 2013 Mar; 8(3):549-58. PubMed ID: 23301619
[TBL] [Abstract][Full Text] [Related]
10. Anecortave acetate.
Bakri SJ; Kaiser PK
Expert Opin Investig Drugs; 2006 Feb; 15(2):163-9. PubMed ID: 16433595
[TBL] [Abstract][Full Text] [Related]
11. Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization.
McNatt LG; Weimer L; Yanni J; Clark AF
J Ocul Pharmacol Ther; 1999 Oct; 15(5):413-23. PubMed ID: 10530702
[TBL] [Abstract][Full Text] [Related]
12. Anecortave (Alcon Laboratories).
Vinores SA
IDrugs; 2005 Apr; 8(4):327-34. PubMed ID: 15800808
[TBL] [Abstract][Full Text] [Related]
13. Suppression of laser-induced choroidal neovascularization by subconjunctival injection of 9alpha-fluoromedroxyprogesterone acetate (FMPA), an anti-angiogenic agent, in rats.
Murata N; Yamaji T; Uchida M; Tsuboi H; Suzuki H; Yamada M; Oikawa T; Nobuhiro J; Choshi T; Hibino S
Biol Pharm Bull; 2006 Dec; 29(12):2410-4. PubMed ID: 17142973
[TBL] [Abstract][Full Text] [Related]
14. Anecortave acetate for the treatment of idiopathic perifoveal telangiectasia: a pilot study.
Eandi CM; Ober MD; Freund KB; Klais CM; Slakter JS; Sorenson JA; Yannuzzi LA
Retina; 2006 Sep; 26(7):780-5. PubMed ID: 16963851
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and metabolism of anecortave acetate in animals and humans.
Dahlin DC; Rahimy MH
Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S49-61. PubMed ID: 17240257
[TBL] [Abstract][Full Text] [Related]
16. Posterior juxtascleral depot administration of anecortave acetate.
Kaiser PK; Goldberg MF; Davis AA;
Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S62-9. PubMed ID: 17240258
[TBL] [Abstract][Full Text] [Related]
17. Increased hypoxia following vessel targeting in a murine model of retinoblastoma.
Boutrid H; Piña Y; Cebulla CM; Feuer WJ; Lampidis TJ; Jockovich ME; Murray TG
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5537-43. PubMed ID: 19578014
[TBL] [Abstract][Full Text] [Related]
18. Multifocal angiostatic therapy: an update.
McCarty MF; Block KI
Integr Cancer Ther; 2005 Dec; 4(4):301-14. PubMed ID: 16282507
[TBL] [Abstract][Full Text] [Related]
19. Anecortave acetate in the treatment of age-related macular degeneration.
Augustin A
Clin Interv Aging; 2006; 1(3):237-46. PubMed ID: 18046876
[TBL] [Abstract][Full Text] [Related]
20. Anecortave acetate for treating or preventing choroidal neovascularization.
Slakter JS
Ophthalmol Clin North Am; 2006 Sep; 19(3):373-80. PubMed ID: 16935212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
